SOCS3 and myeloid sarcoma: Furthermore, monocytes along with CD4+ and CD8+ T cells from patients experiencing relapsing-remitting (RR) MS exhibit reduced expression of SOCS3 during relapse compared to those from patients with remitting MS (47).